Efficiency and Cost-effectiveness of a Culturally Adopted Lifestyle Intervention Program - the MEDIM Study. (MEDIM)
Type 2 Diabetes, Impaired Glucose Tolerance, Obesity
About this trial
This is an interventional prevention trial for Type 2 Diabetes focused on measuring Diabetes type 2, Lifestyle intervention, QALY, Ethnic group, Impaired glucose tolerance, Impaired fasting glucose
Eligibility Criteria
Inclusion Criteria:
- (1) 30 to 75 years of age
- (2) individuals in the baseline survey diagnosed with prediabetes. OR BMI ≥ 28 kg/m2 OR waist >=80 cm in females and >=94cm in males.
Exclusion Criteria:
- pregnancy, severe mental illness, diabetes, and/or cognitive impairment, current CVD or history of CVD events. CVD includes stroke, angina or myocardial infarction (MI), percutaneous transluminal coronary angioplasty (PTCA), congestive heart failure (CHF), coronary artery bypass graft surgery (CABG), transient ischemic attack (TIA) and peripheral vascular disease (PVD) or other physical disorders that prevent physical exercise.
Sites / Locations
- Centre for Primary Health Care Research, Region Skåne and Lund University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Lifestyle intervention
Controls
Lifestyle intervention: 500 participants from Iraq with obesity and/or prediabetes (impaired fasting glucose) and we expect to recruit 308 participants. Half of them will be randomized to lifestyle intervention i.e. group counseling and physical activity during a period of 1 year. An equal amount of controls will have treatment as usual. Every third month blood tests and a physical exam will be conducted in the intervention group.
Controls have treatment as usual. Every third month blood tests and a physical exam will be conducted in the control group.